Gilead, Merck Weekly HIV Pill Keeps Virus Suppressed in Late-stage Trials

Published Date: 23 Jul 2026

Gilead Sciences and Merck said on Tuesday their experimental once-weekly HIV pill kept the virus suppressed in ⁠two late-stage trials, supporting regulatory filings for what...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Do Anatomy Atlases Reflect Social Inequalities?

2.

In Resectable Lung Cancer, Perioperative Nivolumab Increases EFS.

3.

Mammography with AI support is a secure method for detecting breast cancer.

4.

QOL Maintained With Giredestrant Combo in Advanced BC

5.

Talc Powder Not Linked to Lung Cancer in Women


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot